Nomi Biotech

Nomi Biotech is a Polish life science company specializing in the development of bioactive formulations aimed at preventing and managing chronic lifestyle diseases. The company focuses on metabolic disorders, specifically targeting insulin resistance, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD). Utilizing proprietary bioprocessing and extraction technologies, Nomi Biotech produces high-bioavailability compounds, such as their flagship curcumin-based formulation. Their primary commercial product, NOMI Bio-Life, is designed to support glucose metabolism and liver health. By integrating pharmaceutical-grade research with nutritional science, Nomi Biotech provides evidence-based solutions to mitigate the global burden of metabolic syndrome.